These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18975234)

  • 1. GABI-balance--a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
    Chmielewska B; Stelmasiak Z
    Neurol Neurochir Pol; 2008; 42(4):303-11. PubMed ID: 18975234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the effectiveness of add-on therapy with tiagabine and evaluation of cognitive functions after application of this therapy in patients with drug-resistant focal epilepsy - an observational study (GABI-EPI)].
    Halczuk I; Lipa A; Mitosek-Szewczyk K; Sobolewski P; Stelmasiak Z; Kaczyński K
    Wiad Lek; 2015; 68(4 Pt 2):680-9. PubMed ID: 27162312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [GEOS (Gabitril Epilepsy Observational Study) -- Polish results of the international study of tiagabine in partial epilepsy].
    Niedzielska K
    Neurol Neurochir Pol; 2005; 39(6):459-65. PubMed ID: 16355303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiagabine: efficacy and safety in adjunctive treatment of partial seizures.
    Crawford P; Meinardi H; Brown S; Rentmeester TW; Pedersen B; Pedersen PC; Lassen LC
    Epilepsia; 2001 Apr; 42(4):531-8. PubMed ID: 11440349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of twice- and three times daily tiagabine for the adjunctive treatment of partial seizures in refractory patients with epilepsy: an open label, randomised, parallel-group study.
    Biraben A; Beaussart M; Josien E; Pestre M; Savet JF; Schaff JL; Tourniaire D; Sevestre M; Renault-Djouadi J
    Epileptic Disord; 2001 Jun; 3(2):91-100. PubMed ID: 11431171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: pooled analysis of two long-term, randomized, follow-up studies.
    Aikiä M; Jutila L; Salmenperä T; Mervaala E; Kälviäinen R
    Epilepsia; 2006 Jul; 47(7):1121-7. PubMed ID: 16886974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tiagabine (gabitril) experience in children.
    Pellock JM
    Epilepsia; 2001; 42 Suppl 3():49-51. PubMed ID: 11520324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiagabine as add-on therapy may be more effective with valproic acid--open label, multicentre study of patients with focal epilepsy.
    Jedrzejczak J
    Eur J Neurol; 2005 Mar; 12(3):176-80. PubMed ID: 15693805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determinants of tiagabine (TGB) efficacy and safety. A Polish multicenter study of 1307 patients with focal epilepsy].
    Kozik A; Krause M
    Neurol Neurochir Pol; 2003; 37(3):537-46. PubMed ID: 14593750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of controlled trials of gabitril (tiagabine): a clinician's viewpoint.
    Loiseau P
    Epilepsia; 1999; 40 Suppl 9():S14-9. PubMed ID: 10612357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiagabine monotherapy in the treatment of partial epilepsy.
    Schachter SC
    Epilepsia; 1995; 36 Suppl 6():S2-S6. PubMed ID: 8595789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of adjunctive therapy with tiagabine in mentally disabled patients with epilepsy.
    Chmielewska B; Stelmasiak Z
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):226-36. PubMed ID: 12898928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiagabine.
    Schachter SC
    Epilepsia; 1999; 40 Suppl 5():S17-22. PubMed ID: 10530690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International experience with tiagabine add-on therapy.
    Ben-Menachem E
    Epilepsia; 1995; 36 Suppl 6():S14-S21. PubMed ID: 8595788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures. Northern European Tiagabine Study Group.
    Kälviäinen R; Brodie MJ; Duncan J; Chadwick D; Edwards D; Lyby K
    Epilepsy Res; 1998 Mar; 30(1):31-40. PubMed ID: 9551842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of tiagabine: a prospective open-label study.
    Bauer J; Bergmann A; Reuber M; Stodieck SR; Genton P
    Epileptic Disord; 2002 Dec; 4(4):257-60. PubMed ID: 12600812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of Gabitril and Lamictal for drug-resistant epilepsy in adults.
    Chmielewska B; Stelmasiak Z
    Ann Univ Mariae Curie Sklodowska Med; 2001; 56():35-42. PubMed ID: 11977339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.